CD8A and neoplasm: Supernatant derived from SCC tumours is known to increase the frequency of CD8+ T cells that produce IFN-γ [20], and indeed the quantitation of IFN-γ in the serum of SCC patients is reportedly a useful indicator of tumour progression [21].